# UPTRAVI
> **NDA207947** · New Drug Application · Sponsor: ACTELION · Approved 2015-12-21
## Drug
- **FDA Application Number:** NDA207947
- **Application type:** New Drug Application
- **Brand name:** UPTRAVI
- **Generic name:** SELEXIPAG
- **Active ingredients:** SELEXIPAG
- **Dosage form:** TABLET
- **Route:** ORAL
- **Marketing status:** Prescription
- **Sponsor:** ACTELION
- **Manufacturer:** Actelion Pharmaceuticals US, Inc.
- **First approval:** 2015-12-21
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=207947)
---
*AI Analytics · CC0 1.0*